Related references
Note: Only part of the references are listed.Dosing Guidance for Intravenous Colistin in Critically Ill Patients
Roger L. Nation et al.
CLINICAL INFECTIOUS DISEASES (2017)
Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant Enterobacteriaceae
Elizabeth A. Neuner et al.
VIRULENCE (2017)
Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility
Alexandre P. Zavascki et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2017)
Modifiable Risk Factors for the Spread of Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Among Long-Term Acute-Care Hospital Patients
Koh Okamoto et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2017)
In vitro antibacterial activity of fosfomycin combined with other antimicrobials against KPC-producing Klebsiella pneumoniae
Wei Yu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Belen Gutierrez-Gutierrez et al.
LANCET INFECTIOUS DISEASES (2017)
Successful ceftazidime-avibactam treatment of MDR-KPC-positive Klebsiella pneumoniae infection in a patient with traumatic brain injury A case report
Agnese Gugliandolo et al.
MEDICINE (2017)
Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial A Randomized Clinical Trial
Joseph Solomkin et al.
JAMA SURGERY (2017)
Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of Literature
Ryan K. Shields et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Genomic epidemiology of global Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli
N. Stoesser et al.
SCIENTIFIC REPORTS (2017)
Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study
Gennaro De Pascale et al.
CRITICAL CARE (2017)
Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections
Madeline King et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Correlation of β-Lactamase Production and Colistin Resistance among Enterobacteriaceae Isolates from a Global Surveillance Program
Patricia A. Bradford et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae
Jessica B. Cprek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains
Naoki Kohira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B
Maria Helena Rigatto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Bacteremia
Gary Wu et al.
CLINICAL INFECTIOUS DISEASES (2016)
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
George G. Zhanel et al.
DRUGS (2016)
Combination treatment with extended-infusion ceftazidime/avibactam for a KPC-3-producing Klebsiella pneumoniae bacteraemia in a kidney and pancreas transplant patient
David M. Jacobs et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Rise and fall of KPC-producing Klebsiella pneumoniae in New York City
Marie Abdallah et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study
Yehuda Carmeli et al.
LANCET INFECTIOUS DISEASES (2016)
Carbapenem-ResistantKlebsiella pneumoniaeInfection in Three New York City Hospitals Trended Downwards From 2006 to 2014
Sun O. Park et al.
Open Forum Infectious Diseases (2016)
Effect of Resistance Mechanisms on the Inoculum Effect of Carbapenem in Klebsiella pneumoniae Isolates with Borderline Carbapenem Resistance
Amos Adler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate
Romney M. Humphries et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City
Amabel Lapuebla et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Heteroresistance to Colistin in Klebsiella pneumoniae Associated with Alterations in the PhoPQ Regulatory System
Aurelie Jayol et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Activity of Meropenem Combined with RPX7009, a Novel beta-Lactamase Inhibitor, against Gram-Negative Clinical Isolates in New York City
Amabel Lapuebla et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
Johann D. D. Pitout et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013)
Hello S. Sader et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2015)
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
Mario Tumbarello et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Fecal Microbiota Transplantation and Successful Resolution of Multidrug-Resistant-Organism Colonization
Nancy F. Crum-Cianflone et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City
Marie Abdallah et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Contaminated Handwashing Sinks as the Source of a Clonal Outbreak of KPC-2-Producing Klebsiella oxytoca on a Hematology Ward
Eva Leitner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Prevention of Colonization and Infection by Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae in Long-term Acute-Care Hospitals
Mary K. Hayden et al.
CLINICAL INFECTIOUS DISEASES (2015)
Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria
Phillip J. Bergen et al.
INFECTIOUS DISEASES AND THERAPY (2015)
Long-term carriage of Klebsiella pneumoniae carbapenemase-2-producing K pneumoniae after a large single-center outbreak in Germany
Christoph Luebbert et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2014)
In Vitro Assessment and Multicenter Cohort Study of Comparative Nephrotoxicity Rates Associated with Colistimethate versus Polymyxin B Therapy
Kady Phe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Surveillance of Carbapenem-Resistant Klebsiella pneumoniae: Tracking Molecular Epidemiology and Outcomes through a Regional Network
David van Duin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Case-Case-Control Study of Patients with Carbapenem-Resistant and Third-Generation-Cephalosporin-Resistant Klebsiella pneumoniae Bloodstream Infections
Jason C. Gallagher et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Treating infections caused by carbapenemase-producing Enterobacteriaceae
L. S. Tzouvelekis et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections
Alessandra Oliva et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Klebsiella pneumoniae Bloodstream Infection Epidemiology and Impact of Inappropriate Empirical Therapy
Nicolo Girometti et al.
MEDICINE (2014)
Activity of Ceftaroline-Avibactam Tested Against Contemporary Enterobacteriaceae Isolates Carrying β-Lactamases Prevalent in the United States
Mariana Castanheira et al.
MICROBIAL DRUG RESISTANCE (2014)
Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit
Matthaios Papadimitriou-Olivgeris et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2014)
Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
J. A. Sutcliffe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Carbapenem-Sparing Antibiotic Regimens for Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit
Francesco Sbrana et al.
CLINICAL INFECTIOUS DISEASES (2013)
Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
Ana M. Sandri et al.
CLINICAL INFECTIOUS DISEASES (2013)
Higher Incidence of Acute Kidney Injury With Intravenous Colistimethate Sodium Compared With Polymyxin B in Critically Ill Patients at a Tertiary Care Medical Center
Darowan S. Akajagbor et al.
CLINICAL INFECTIOUS DISEASES (2013)
Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes
David van Duin et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010
Dawn M. Sievert et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2013)
Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Fosfomycin susceptibility of isolates with blaKPC-2 from Brazil
Felipe F. Tuon et al.
JOURNAL OF INFECTION (2013)
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
L. Silvia Munoz-Price et al.
LANCET INFECTIOUS DISEASES (2013)
KPC-3 Klebsiella pneumoniae ST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: analysis of a case series of 30 patients
Paola Di Carlo et al.
BMC ANESTHESIOLOGY (2013)
Treatment and Clinical Outcomes of Urinary Tract Infections Caused by KPC-Producing Enterobacteriaceae in a Retrospective Cohort
Bryan T. Alexander et al.
CLINICAL THERAPEUTICS (2012)
Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new?
Phillip J. Bergen et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Transfer from High-Acuity Long-Term Care Facilities Is Associated with Carriage of Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae: A Multihospital Study
Kavitha Prabaker et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2012)
Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor
David E. Ehmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Evaluation of Ceftazidime and NXL104 in Two Murine Models of Infection Due to KPC-Producing Klebsiella pneumoniae
Andrea Endimiani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
Catharine C. Bulik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
S. M. Garonzik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Comparative Effectiveness of Aminoglycosides, Polymyxin B, and Tigecycline for Clearance of Carbapenem-Resistant Klebsiella pneumoniae from Urine
Michael J. Satlin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
Antonio T. Freire et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Resistance to polymyxins: Mechanisms, frequency and treatment options
Matthew E. Falagas et al.
DRUG RESISTANCE UPDATES (2010)
Successful Control of an Outbreak of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae at a Long-Term Acute Care Hospital
L. Silvia Munoz-Price et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Consensus Summary of Aerosolized Antimicrobial Agents: Application of Guideline Criteria Insights from the Society of Infectious Diseases Pharmacists
Jennifer Le et al.
PHARMACOTHERAPY (2010)
Regional Dissemination of KPC-Producing Klebsiella pneumoniae
Brandon Kitchel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
In Vitro Activity of NXL104 in Combination with β-Lactams against Klebsiella pneumoniae Isolates Producing KPC Carbapenemases
Andrea Endimiani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
Gopi Patel et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Klebsiella pneumoniae carbapenemase-2, Buenos Aires, Argentina
Fernando G. Pasteran et al.
EMERGING INFECTIOUS DISEASES (2008)
Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: Report from the MYSTIC Program (1999-2005)
Lalitagauri M. Deshpande et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2006)
Mutators among CTX-M β-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance
Matthew J. Ellington et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenem
JL Kuti et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class a carbapenemase KPC-2
V Miriagou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Plasmid-mediated, carbapenem-hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae isolates
ES Moland et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Share Paper
